Huang Qizhi, Mitchell Caroline, Theodoulou Elisavet, Lee Andrew C K, Brown Janet
Population Health, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
Faculty of Medicine and Health Sciences, Keele University, Keele, UK.
J Cancer Surviv. 2024 Aug 14. doi: 10.1007/s11764-024-01659-3.
Androgen deprivation therapy (ADT) is a mainstay of treatment for prostate cancer (PCa) and is associated with increased risks of osteoporosis and fragility fractures. Despite international guidelines to mitigate fracture risk, osteoporosis is under-diagnosed and under-treated due to poor implementation. This scoping review aims to synthesise knowledge surrounding the implementation of guidelines to inform health service interventions to reduce fracture risk in men with PCa-taking ADT (PCa-ADT).
Four databases and additional literature were searched for studies published between January 2000 and January 2023. Studies that provided evidence influencing guidelines implementation were included. The i-PARIHS (Promoting Action on Research Implementation in Health Services) implementation framework was used to inform the narrative synthesis.
Of the 1229 studies identified, 9 studies met the inclusion criteria. Overall, an improvement in fracture risk assessment was observed across heterogeneous study designs and outcome measures. Six studies were from Canada. Two studies involved family physicians or a community healthcare programme. Two studies incorporated patient or specialist surveys. One utilised an implementation framework. Implementation barriers included the lack of knowledge for both patients and clinicians, time constraints, unsupportive organisational structures, and challenges in transferring patient care from specialists to primary care. Effective strategies included education, novel care pathways using a multidisciplinary approach, incorporating a healthy bone prescription tool into routine care, point-of-care interventions, and bespoke clinics.
There is an unmet need to provide evidence-based bone healthcare in men with PCa receiving ADT. This study highlights barriers and strategies in the implementation of fracture risk assessment for PCa-ADT patients.
Primary care clinicians can play a significant role in the management of complications from long-term cancer treatment such as treatment-induced bone loss. Future studies should consult patients, families, specialists, and primary care clinicians in service re-design.
雄激素剥夺疗法(ADT)是前列腺癌(PCa)治疗的主要手段,且与骨质疏松和脆性骨折风险增加相关。尽管有国际指南来降低骨折风险,但由于实施不力,骨质疏松的诊断和治疗不足。本范围综述旨在综合有关指南实施的知识,为卫生服务干预提供信息,以降低接受ADT的PCa男性(PCa-ADT)的骨折风险。
检索了四个数据库及其他文献,以查找2000年1月至2023年1月发表的研究。纳入提供影响指南实施证据的研究。使用i-PARIHS(促进卫生服务研究实施行动)实施框架来指导叙述性综合分析。
在识别出的1229项研究中,9项研究符合纳入标准。总体而言,在不同的研究设计和结局指标中均观察到骨折风险评估有所改善。6项研究来自加拿大。2项研究涉及家庭医生或社区医疗保健项目。2项研究纳入了患者或专家调查。1项研究使用了实施框架。实施障碍包括患者和临床医生缺乏知识、时间限制、不支持的组织结构以及将患者护理从专科医生转移到初级保健的挑战。有效策略包括教育、采用多学科方法的新型护理途径、将健康骨骼处方工具纳入常规护理、即时护理干预以及定制诊所。
在接受ADT的PCa男性中,提供基于证据的骨骼医疗保健的需求尚未得到满足。本研究强调了PCa-ADT患者骨折风险评估实施中的障碍和策略。
初级保健临床医生在长期癌症治疗并发症(如治疗引起的骨质流失)的管理中可发挥重要作用。未来研究应在服务重新设计中咨询患者、家庭、专科医生和初级保健临床医生。